Michael D. Robek, Ph.D.
Affiliations: | 2000 | Washington University, Saint Louis, St. Louis, MO |
Area:
Microbiology Biology, Immunology, Cell BiologyGoogle:
"Michael Robek"Parents
Sign in to add mentorLee Ratner | grad student | 2000 | Washington University | |
(Role of the viral pX region encoded proteins in the transformation of T lymphocytes by the human T -cell leukemia virus type 1.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Bailey JT, Moshkani S, Rexhouse C, et al. (2023) CD4 T cells reverse surface antigen persistence in a mouse model of HBV replication. Microbiology Spectrum. e0344723 |
Schmidt S, Mengistu M, Daffis S, et al. (2023) Alternating arenavirus vector immunization generates robust polyfunctional genotype cross-reactive HBV-specific CD8 T cell responses and high anti-HBs titers. The Journal of Infectious Diseases |
Chiale C, Marchese AM, Furuya Y, et al. (2021) Virus-based vaccine vectors with distinct replication mechanisms differentially infect and activate dendritic cells. Npj Vaccines. 6: 138 |
Chiale C, Marchese AM, Robek MD. (2021) Innate immunity and HBV persistence. Current Opinion in Virology. 49: 13-20 |
Chiale C, Yarovinsky TO, Mason SW, et al. (2020) Modified Alphavirus-Vesiculovirus Hybrid Vaccine Vectors for Homologous Prime-Boost Immunotherapy of Chronic Hepatitis B. Vaccines. 8 |
Yarovinsky TO, Mason SW, Menon M, et al. (2019) Virus-like Vesicles Expressing Multiple Antigens for Immunotherapy of Chronic Hepatitis B. Iscience. 21: 391-402 |
Marchese AM, Chiale C, Moshkani S, et al. (2019) Mechanisms of Innate Immune Activation by a Hybrid Alphavirus-Rhabdovirus Vaccine Platform. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research |
Chiale C, Moshkani S, Rose JK, et al. (2019) Heterologous prime-boost immunization with vesiculovirus-based vectors expressing HBV core antigen induces CD8 T cell responses in naïve and persistently infected mice and protects from challenge. Antiviral Research |
Moshkani S, Chiale C, Lang SM, et al. (2018) A highly attenuated vesicular stomatitis virus-based vaccine platform controls HBV replication in mouse models of hepatitis B. Journal of Virology |
Reynolds TD, Moshkani S, Robek MD. (2017) An ELISPOT-Based Assay to Measure HBV-Specific CD8(+) T Cell Responses in Immunocompetent Mice. Methods in Molecular Biology (Clifton, N.J.). 1540: 237-247 |